Expression analysis of SOX2 and SOX9 in patients with oral squamous cell carcinoma
Head & Neck · 2025
DOI: 10.1002/hed.27925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Sonja Steen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Cranio-Maxillofacial Surgery, University of Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: SOX9 Transcription Factor, SOXB1 Transcription Factors, Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lately SOX2 and SOX9, transcription factors associated with stemness‐like phenotypes of cancer cells, have been linked to tumor growth, metastasis, and resistance to therapy.
Methods
This study aimed on evaluating the expression of SOX2 and SOX9 in a large cohort of patients with OSCC including primary and recurrent tumors and corresponding lymph node metastases. Semiautomatic digital pathology scoring was used to determine protein expression and survival analysis was performed to evaluate its prognostic significance.
Results
We found a significant downregulation of SOX9 from primary disease to lymph node metastases ( p < 0.001). SOX9 expression and the subgroup SOX2 low SOX9 high were significantly correlated with worse overall survival ( p < 0.05). Additionally, SOX2 low SOX9 high expression pattern was confirmed as independent prognosticator for overall survival.
Conclusions
These results indicate the relevant role of SOX2 and SOX9 in patients with OSCC and show the clinical relevance for further investigation on the molecular mechanisms underlying SOX‐related gene expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Cranio-Maxillofacial Surgery, University of Heidelberg, Heidelberg, Germany.
- Department of Oral and Cranio-Maxillofacial Surgery, Saarland University Hospital, Homburg, Germany.
- Tissue Bank of the National Center for Tumor Diseases (NCT), Heidelberg, Germany.
- Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
- Department of Otorhinolaryngology - Head and Neck Surgery, University of Heidelberg, Heidelberg, Germany.
ORCID-Profile: Julius Moratin
Zitieren
APA
Steen, S., Horn, D., Flechtenmacher, C., Hoffmann, J., Freier, K., Ristow, O., Hess, J., & Moratin, J. (2025). Expression analysis of SOX2 and SOX9 in patients with oral squamous cell carcinoma. Head & Neck. https://doi.org/10.1002/hed.27925
Vancouver
Steen S, Horn D, Flechtenmacher C, Hoffmann J, Freier K, Ristow O, et al. Expression analysis of SOX2 and SOX9 in patients with oral squamous cell carcinoma. Head & Neck. 2025. doi:10.1002/hed.27925
BibTeX
@article{Steen2025,
author = {Steen, Sonja and Horn, Dominik and Flechtenmacher, Christa and Hoffmann, Jürgen and Freier, Kolja and Ristow, Oliver and Hess, Jochen and Moratin, Julius},
title = {Expression analysis of SOX2 and SOX9 in patients with oral squamous cell carcinoma},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.27925}
}
EUVIMED